31 January 2007
Additional Listing
Futura Medical plc (the "Company"), the AIM-listed pharmaceutical group that develops innovative products for consumer healthcare with expertise in sexual health, has applied for 50,000 new ordinary shares of 0.2p each in the Company to be admitted to trading on the AIM market of the London Stock Exchange. The shares are being issued following the exercise of options.
The shares will rank pari passu with existing ordinary shares and dealings are expected to commence in the new ordinary shares at 8.00am on 5 February 2007. Pursuant to AIM Notice 26, the Company's total issued share capital following the anticipated admission of the shares as set out above is 55,353,601.
For any further information please contact:
Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.co.uk
www.futuramedical.co.uk
For any media enquiries please contact:
Buchanan Communications Limited
Mark Court
Rebecca Skye Dietrich
+44 (0) 20 7466 5000